Michael H Carrel is President, CEO, & Director of AtriCure, Inc.. Currently has a direct ownership of 653,239 shares of ATRC, which is worth approximately $23.5 Million. The most recent transaction as insider was on Feb 12, 2021, when has been sold 25,000 shares (Common Stock) at a price of $21.04 per share, resulting in proceeds of $526,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 653K
0% 3M change
9.72% 12M change
Total Value Held $23.5 Million

MICHAEL H CARREL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2021
BUY
Exercise of conversion of derivative security
$526,000 $21.04 p/Share
25,000 Added 4.51%
529,795 Common Stock
Feb 11 2021
SELL
Open market or private sale
$1,600,000 $64.0 p/Share
25,000 Reduced 4.72%
504,795 Common Stock
Feb 11 2021
BUY
Exercise of conversion of derivative security
$526,000 $21.04 p/Share
25,000 Added 4.51%
529,795 Common Stock
Feb 10 2021
SELL
Open market or private sale
$1,575,000 $63.0 p/Share
25,000 Reduced 4.72%
504,795 Common Stock
Feb 10 2021
BUY
Exercise of conversion of derivative security
$526,000 $21.04 p/Share
25,000 Added 4.51%
529,795 Common Stock
Feb 09 2021
SELL
Open market or private sale
$1,550,000 $62.0 p/Share
25,000 Reduced 4.72%
504,795 Common Stock
Feb 09 2021
BUY
Exercise of conversion of derivative security
$526,000 $21.04 p/Share
25,000 Added 4.51%
529,795 Common Stock
Feb 08 2021
SELL
Open market or private sale
$1,525,000 $61.0 p/Share
25,000 Reduced 4.72%
504,795 Common Stock
Feb 08 2021
BUY
Exercise of conversion of derivative security
$526,000 $21.04 p/Share
25,000 Added 4.51%
529,795 Common Stock
Feb 02 2021
SELL
Open market or private sale
$1,500,000 $60.0 p/Share
25,000 Reduced 4.72%
504,795 Common Stock
Feb 02 2021
BUY
Exercise of conversion of derivative security
$526,000 $21.04 p/Share
25,000 Added 4.51%
529,795 Common Stock
Jan 11 2021
SELL
Open market or private sale
$1,475,000 $59.0 p/Share
25,000 Reduced 4.72%
504,795 Common Stock
Jan 11 2021
BUY
Exercise of conversion of derivative security
$526,000 $21.04 p/Share
25,000 Added 4.51%
529,795 Common Stock
Dec 31 2020
BUY
Grant, award, or other acquisition
$11,198 $38.48 p/Share
291 Added 0.06%
504,795 Common Stock
Dec 28 2020
SELL
Open market or private sale
$1,447,274 $58.0 p/Share
24,953 Reduced 4.71%
504,504 Common Stock
Dec 28 2020
BUY
Exercise of conversion of derivative security
$525,011 $21.04 p/Share
24,953 Added 4.5%
529,457 Common Stock
Dec 23 2020
SELL
Open market or private sale
$2,726 $58.0 p/Share
47 Reduced 0.01%
504,504 Common Stock
Dec 23 2020
BUY
Exercise of conversion of derivative security
$989 $21.04 p/Share
47 Added 0.01%
504,551 Common Stock
Dec 22 2020
SELL
Open market or private sale
$2,825,000 $56.5 p/Share
50,000 Reduced 9.02%
504,504 Common Stock
Dec 22 2020
BUY
Exercise of conversion of derivative security
$1,052,000 $21.04 p/Share
50,000 Added 8.63%
529,504 Common Stock
Dec 21 2020
SELL
Open market or private sale
$1,361,305 $55.0 p/Share
24,751 Reduced 4.68%
504,504 Common Stock
Dec 21 2020
BUY
Exercise of conversion of derivative security
$520,761 $21.04 p/Share
24,751 Added 4.47%
529,255 Common Stock
Dec 18 2020
SELL
Open market or private sale
$2,688,824 $53.51 p/Share
50,249 Reduced 9.06%
504,504 Common Stock
Dec 18 2020
BUY
Exercise of conversion of derivative security
$1,057,239 $21.04 p/Share
50,249 Added 8.31%
554,753 Common Stock
Dec 17 2020
SELL
Open market or private sale
$3,825,000 $51.0 p/Share
75,000 Reduced 12.94%
504,504 Common Stock

Also insider at

AXNX
Axonics, Inc. Healthcare
MHC

Michael H Carrel

President, CEO, & Director
Mason, OH

Track Institutional and Insider Activities on ATRC

Follow AtriCure, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

News

Receive news related to AtriCure, Inc.

Track Activities on ATRC